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ABSTRACT This article reports anall-atommolecular dynamics simulation to studyamodel pulmonary surfactant ﬁlm interacting
with a carbonaceous nanoparticle. The pulmonary surfactant is modeled as a dipalmitoylphosphatidylcholine monolayer with a
peptide consisting of the ﬁrst 25 residues from surfactant protein B. The nanoparticle model with a chemical formula C188H53 was
generated using a computational code for combustion conditions. The nanoparticle has a carbon cage structure reminiscent of the
buckyballswith openends. A series ofmolecular-scale structural anddynamical properties of the surfactant ﬁlm in the absenceand
presence of nanoparticle are analyzed, including radial distribution functions, mean-square displacements of lipids and nano-
particle, chain tilt angle, and the surfactant protein B peptide helix tilt angle. The results show that the nanoparticle affects the
structure and packing of the lipids and peptide in the ﬁlm, and it appears that the nanoparticle and peptide repel each other. The
ability of the nanoparticle to translocate the surfactant ﬁlm is one of the most important predictions of this study. The potential of
mean force for dragging the particle through the ﬁlm provides such information. The reported potential of mean force suggests that
the nanoparticle can easily penetrate the monolayer but further translocation to the water phase is energetically prohibitive. The
implication is that nanoparticles can interact with the lung surfactant, as supported by recent experimental data by Bakshi et al.
INTRODUCTION
The process of combustion is, at this time, the dominant
pathway through which mankind continuously injects partic-
ulate matter into the atmosphere. These combustion-generated
particles are produced not only in very large amounts, but, at
the smallest scale, in the form of clusters with nanometric
dimensions. Modern diesel engines are a major source of
these combustion-generated nanoparticles. Although the total
mass of particulate emissions has been signiﬁcantly reduced
with the improvement of combustion efﬁciency and emis-
sions control systems, the very small nanoparticles are
exceedingly difﬁcult to control by the emission systems typ-
ically installed on vehicles. In addition, the current emission
regulations are mass-based and do not address the presence
of nanoparticles. In fact, studies conducted on exhaust mea-
surements of particle size and number concentration data
from diesel engines (1–5) show that nanoparticles represent
only 0.1–1.5% of particle volume (mass) but 35–97% of the
particle number (6). Environmental regulations of diesel en-
gines and other combustion sources based on particle mass or
volume instead of particle number will nearly entirely miss
the dangerous nanoparticle component of such emissions. For
example, currently U.S. Environmental Protection Agency
and European Union regulations on diesel engines will con-
trol particle sizes down to 2.5 mm, fully two to three orders of
magnitude larger than the dimension of the nanoparticles that
have been experimentally shown to dominate the diesel par-
ticle number emissions proﬁle. (Particle mass, rather than
number, is the basis for the new diesel regulations). Given that
such great quantities of carbonaceous nanoparticles are being
introduced into the atmosphere by combustion sources, the
question naturally arises as to their environmental fate. The
most direct and serious risk would seem to be the direct
absorption of these particles into living human and animal
systems through the process of respiration, especially in more
urban environments (7). Recent studies on themechanisms by
which ultraﬁne particles act on biological systems reveal that
particle deposition on the epithelial cells in the lungs trigger a
number of responses: cell activation leading to inﬂammation
(8–10); production of cytokines (proteins) that stimulate the
release of ﬁbrinogens, which bind to platelets, contribute to
their aggregation, and enhance their ability to clot; and stim-
ulation of nerve cells that leads to changes in the nervous
system’s control of breathing and heart rate (11–13). The goal
of this work is therefore to explore the interactions of carbon-
based nanoparticles derived from combustion sources with
biomolecular structures representative of those in the lung
(pulmonary surfactant) using atomistic simulations. To date,
little is known about the interaction of ultraﬁne particles with
the lung surfactant. Recent studies reported by Geiser et al.
(14) andKapp et al. (15) show that the surfactant promotes the
displacement of particles from air into an aqueous subphase
and the extent of particle immersion depends on the surface
tension of the surfactant ﬁlm. Inhaled particles, regardless of
the nature of their surfaces, are submersed into the lining layer
after deposition in small airways and alveoli. The displace-
ment is promoted by the surfactant ﬁlm at the air-liquid in-
terface, whose surface tension temporarily falls to relatively
low values. It is important to note that Nemmar et al. (16) have
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shown the passage of inhaled 99mTc-carbon particles into the
blood circulation in humans. Oberdorster et al. (17) reported
the substantial translocation of inhaled 13C-carbon particles
into the liver after whole-body inhalation exposure of rats. In
other words, the inhaled material may have the respiratory
system as its target organ or the respiratory system may only
be a route of entry to the body. Recently, Bakshi et al. (18)
examined the potential effects of metal nanoparticles (Au
NP), as a model air pollutant, on the surface activity of a
semisynthetic pulmonary surfactant, dipalmitoylphospha-
tidylcholine/palmitoyloleoylphosphatidylglycerol/surfactant
protein B (DPPC/POPG/SP-B, 70:30:1). The presence of Au
NP at 3.7 mol %, 0.98 wt % (Au/phospholipids) dramatically
reduced the surface activity of the surfactant system.
In this work, we report on the computational investigation
of the structural and dynamic effects of combustion-generated
carbon nanoparticles on a lipid monolayer using molecular
dynamics (MD) simulations of atomistic molecular models.
In the next section, the molecular models and computer sim-
ulation methods used in this study are described in detail.
Structural, dynamical, and thermodynamical analyses are
then presented. It is found that the presence of nanoparticles
inside the lung surfactant inﬂuences the lipid/peptide envi-
ronment.
METHODS
Molecular models
Monolayer
Pulmonary lung surfactant (LS) is a mixture of lipids and proteins, and its
main biophysical function is the reduction of surface tension at the air-liquid
interface. This reduction stabilizes the alveoli during expiration, when the
alveolar space faces the highest compressions, and reduces the amount of
work required to reexpand the lung during the next respiratory cycle (19–22).
LS consists of;90% lipids (23) and 10% proteins (24,25). DPPC constitutes
over 40% of the total weight of surfactant. LS works both by lowering the
normal surface tension to near zero inside the lungs to reduce the work of
breathing, and by stabilizing the alveoli through varying the surface tension
as a function of alveolar volume (26). To accomplish this, the LS mixture
must adsorb rapidly to the air-ﬂuid interface of the alveoli after being se-
creted. Once at the interface, it must form a monolayer that can both achieve
low surface tensions upon compression and vary the surface tension as a
function of the alveolar radius. This monolayer must also be able to resist
collapse under the compression that accompanies exhalation. LS also con-
tains four lung-surfactant-speciﬁc proteins, known as SP-A, SP-B, SP-C, and
SP-D. SP-A and SP-D are larger proteins thought to be responsible for the
transport and recycling of LS, whereas SP-B and SP-C are smaller helical
proteins believed to be important for its surface activity.
In vitro studies suggest that SP-B interacts with the headgroups of acidic
surfactant lipids and enhances the adsorption, spreadability, and surface in-
sertion of the surfactant lipids (19,24,27). In many instances, SP-B1–25 (the
ﬁrst 25 amino acids) can effectively replace the full-length SP-B (28–34).
Based on previously reported MD simulation studies of LS (35,36), the mo-
del LS system used in this work is composed of DPPC along with SP-B1–25,
which has been demonstrated to have functions that are indispensable for LS
surface activity, similar to those of full-length SP-B. In particular, we
performed a series of MD simulations on a system composed of a lipid
monolayer containing 90 DPPC molecules, two pulmonary SP-B1–25s,
;5500 water molecules, and an appropriate number of counterions (Cl) to
maintain electroneutrality of the system (System I). The system is composed
of two leaﬂets, with 45 lipids and one peptide in each leaﬂet. The peptide
structure and coordinates were downloaded from the Protein Data Bank
(code 1DFW). This latter system was then modiﬁed to allocate two iden-
tical carbonaceous nanoparticles (one nanoparticle per leaﬂet) to produce
System II.
Nanoparticle
A combustion-generated carbon nanoparticle was produced using the AMPI
(AtomisticModel for Particle Inception) code that was developed to study the
transformations that occur in combustion systems during the transition from
gas phase to particle inception (37). The particle has an aspect ratio close to
unity, with a formula of C188H53. It has a size of ;17 A˚ in the longest di-
mension and consists of a network of ﬁve- to eight-membered fused rings
resembling buckyballs. The capability of theAMPI code has been validated in
different combustion conditions. Nanoparticles have been characterized in
terms of chemical structure/components and relationships between structure
and pathways, structure and properties, and structure and reactivity popula-
tion of active sites have been addressed. In particular, computed properties of
nanoparticles have been compared with experimental data in terms of H/C
trends, particle morphology and depolarization ratio, and free radical con-
centration (38–42).
Molecular dynamics simulations
Monolayer conﬁguration and equilibration
The initial monolayer conﬁguration was obtained by replicating a single
DPPCmolecule 45 times as a monolayer in a box of size 5.03 5.03 20 nm.
Below the headgroup region of the monolayer, 2750 water molecules were
added, and periodic boundary conditions were applied in all three directions.
The TIP3P model was used for the water molecules (43,44). The second
leaﬂet was obtained by 180 rotation of the ﬁrst leaﬂet. The simulation box
length was set to 20.0 nm in the z direction to make sure that the interaction
between the system and its periodic image was minimal. A conﬁguration
made of a two-leaﬂet system for the monolayer simulations has been widely
used in the past. Previous studies have shown that monolayer systems of
several nanometers in size can reproduce most of the structural properties
experimentally observed (45).
A cutoff of 1.2 nm was used for the van der Waals interactions and the
particle mesh Ewald summation (46) was employed with k ¼ 0.34 A˚1 for
electrostatic interactions. The temperature wasmaintained at 325K, coupling
the system to aNose-Hoover thermostat (47), and theLangevin pistonmethod
(48) was used for pressure control. The system was equilibrated for 5 ns. The
ﬁnal conﬁguration from this equilibration simulation was used as the starting
condition for the next step.
Peptide insertion and equilibration
The sequence of SP-B1–25 in humans is FPIPL PYCWL CRALI KRIQA
MIPKG. The ﬁrst eight residues are highly hydrophobic and are hypothe-
sized to form an insertion sequence, and this part of the protein is relatively
inﬂexible due to the presence of three alternating proline residues. Residues
9–22 form an amphipathic a-helix, and the last three residues form a coil
motif. A ribbon diagram of SP-B1–25 is shown in Fig. 1. SP-B1–25 was in-
serted into the equilibrated monolayer. The insertion was obtained by run-
ning an MD simulation with an additional hole-making force in the lipid
monolayer region. After the peptide was inserted into the hole, an energy
minimization step was performed. Then, an appropriate number of coun-
terions was added to ensure electroneutrality of the system. An equilibration
run of 1 ns was then performed using the NLZgT ensemble, allowing the
lipids to equilibrate around the peptide. The ﬁnal conﬁguration deﬁnes one of
the two systems analyzed in this article, System I.
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Carbonaceous nanoparticle insertion and equilibration
The nanoparticle was inserted into the equilibrated peptide 1 monolayer
system according to a procedure similar to that described for the peptide.
Every time the radius of the hole was increased, the system was minimized
using the adopted-basis Newton Raphson algorithm (49). Once the nano-
particle was inserted into the hole, the system was equilibrated for 1 ns. The
ﬁnal conﬁguration represents the second system of interest in this work,
System II (see Fig. 2). The carbonaceous nanoparticle does not possess any
electric charge or dipole, and the interactions between the nanoparticles in the
two leaﬂets, nanoparticles and lipids or water molecules, are mainly due to
the short-range van der Waals (vdW) potential. For the nanoparticle we used
the aromatic carbon parameters of the CHARMM force ﬁelds.
The objective of this study is to compare Systems I and II to understand
how the presence of the nanoparticle inﬂuences the main properties of the
monolayer.
Simulation details
MD simulations were performed on Systems I and II in the NLzgT ensem-
ble. The surface tension of the system was kept at g ¼ 20.0 dyn/cm. The
normal surface tension for water is 70 dyn/cm (70 nN/m), and in the lungs it is
25 dyn/cm (25 mN/m); however, at the end of the expiration, compressed
surfactant phospholipid molecules decrease the surface tension to very low,
near-zero levels. Pulmonary surfactant reduces surface tension, increasing
compliance, which allows the lung to inﬂate much more easily, thereby
eliminating the work of breathing. The reduction in surface tension also re-
duces ﬂuid accumulation in the alveolus as the surface tension draws ﬂuid
across the alveolar wall. An additional reason to choose a surface tension of
20.0 dyn/cm was the possibility of comparing our computational results with
previously obtained data (50) to validate our approach. The length of the box
in the z direction (axis perpendicular to the water/lipid interface) was ﬁxed,
whereas the systemcould ﬂuctuate in the x and y directions. Because the height,
Lz, is constrained, the ensemble is actually NLzPTT, where PT is the tangential
pressure. In practice, one could still input an applied surface tension, and
CHARMM would convert the appropriate tangential pressure. NLzPTT was
used in the potential of mean force (PMF) calculation (see below).
The NLZgT ensemble was used with the Nose-Hoover thermostat and a
Langevin piston of mass 500 amu with a collision frequency of 20 ps1. We
set pmxx¼ pmyy¼ 500 amu, and pmzz¼ 0, where pmxx, pmyy, and pmzz are
piston masses applied to the x, y, and z, directions, respectively. The simu-
lations were carried out at 325 K. The SHAKE algorithmwas utilized to hold
all hydrogen bonds ﬁxed. The simulations were run for 7 ns (5 ns), with a
time step of 1 fs for System I (System II). The coordinates were saved every
1 ps to produce a trajectory with 7000 (and 5000) frames that was used for the
analysis. All the simulations were carried out using CHARMM with the
CHARMM27 parameter set (44,49) and VMD (51) for visualizations.
The ﬁnite size effect is not signiﬁcant in these systems as described by
Chang and Violi (52), since the lateral dimension of the monolayer is ;3
times bigger than the nanoparticle size. In addition, it has been shown that an
appropriate distance between the solute protein and a simulation box boun-
dary corresponding to ;4–5 layers of lipid molecules makes it possible to
neglect the size effect (53). Systems I and II fulﬁll these criteria, having a
similar number of lipid layers between the nanoparticle and the box boundary.
Potential of mean force calculation
The PMF associated with the nanoparticle translocation across the mono-
layer has been calculated with the umbrella sampling technique (54) and
weighted histogram analysis method (55). The reaction coordinate of the
PMF was deﬁned separately for each nanoparticle-monolayer pair. Speciﬁ-
cally, they are given as the normal distance between the center of mass of a
nanoparticle and its nearest monolayer, as follows
j1;2 ¼ 6ðzNP1;2  zM1;2Þ; (1)
where zNP1;2 is the z coordinate of the center of mass of nanoparticles 1 and 2,
respectively, and zM1;2 is the corresponding quantity for monolayers 1 and 2.
The 1 and  in the 6 sign on the righthand side of Eq. 1 are for subscripts
1 and 2, respectively. Since the two monolayers are well separated by the
water phase, j1 and j2 are expected to represent two independent nano-
particle translocation events. According to this deﬁnition, the nanoparticle is
FIGURE 1 Initial setup showing one of the leaﬂets. Water molecules and
counterions are deleted for clarity. Orange, round nanoparticles; yellow,
SP-B1–25s; other colors, DPPC lipids.
FIGURE 2 Conﬁguration of the LS/NP system after equilibration, show-
ing the upper leaﬂet (upper) and lower leaﬂet (lower). The particle is re-
presented by vdW radii with red color.
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located in vacuum just outside of the monolayer at j  21 A˚ and it begins to
be exposed to the water phase at j , 5 A˚.
For the PMF calculation, aforementioned System I (monolayer-peptide-
water) was taken and two nanoparticles were placed in vacuum,;2 A˚ above
the upper monolayer and below the lower one, respectively. The system was
then equilibrated for 0.5 ns under constant NPT conditions (P ¼ 1 bar, T ¼
325 K) (47), with harmonic restraints on nanoparticle atomic positions and
the centers of mass of two monolayers. Further equilibration was performed
for 1.25 ns with restraints on the center of mass of each nanoparticle.
From this, the initial conﬁguration for each sampling window was pre-
pared by gradually moving the restraining centers of nanoparticles at a rate of
1.25 A˚/ns across the membrane. It took .30 ns to prepare the various con-
ﬁgurations at different positions in the system. To cover most of the trans-
location event, the position analyzed ranged between –9.5 and 26.25 A˚.
These initial conﬁgurations were then used for umbrella sampling in 144
windows spanning the above range of j, each separated by 0.25 A˚. A har-
monic umbrella potential was employed with a force constant of 100 kcal/
(mol  A˚2) and each window was sampled for 1 ns. Only the last 0.75-ns
portion of the samples was used in the PMF calculation, and the convergence
of PMF was monitored using PMFs from three 0.25-ns subblocks.
During the sampling, the system pressure was maintained at18.7 bar in
the x and y directions. This target lateral pressure was chosen to yield the
surface tension of 20 dyn/cm assuming the normal pressure is 1 bar. The
system height was kept constant by setting the Langevin piston parameter in
that direction to zero. Although the normal pressure in the z direction was not
controlled directly, the surface tension of the system remained close to 20
dyn/cm, indicating that the presence of vacuum region renders the normal
pressure close to 1 bar. For the sampling, the CHARMM code had to be
slightly modiﬁed because Eq. 1. involves only z components.
RESULTS AND DISCUSSION
Surface area
The area/lipid molecule is often used to monitor the system
equilibration during a simulation run and, hence, to assess the
validity of the simulation itself. Fig. 3 shows the time evo-
lution of the area/lipid in Systems I and II. System II, which
includes the nanoparticle, shows a stable surface area during
the 5-ns simulation, with an average value of 59.86 0.6 A˚2/
lipid. The value of the area is obtained by dividing the total
surface area by the number of lipids. The monolayer without
the particle, System I, is stable between 5 and 7 ns. The av-
erage surface area during the last 2 ns is 55.66 0.6 A˚2/lipid,
agreeing well with results obtained by Skibinsky et al. (50)
from previous MD simulations (for a pure DPPC and g ¼
17.1 dyn/cm at T ¼ 323 K).
A larger value of the surface area for System II compared
with System I is not surprising because of the presence of the
nanoparticle. The value of the surface area of the particle is
;5 A˚2/lipid (radius ;8 A˚), so the computed surface area/
lipids of ;60 A˚2 for System II seems reasonable. As can be
noted from Fig. 3, the presence of the nanoparticle has a small
effect on the area/lipid.
Radial distribution functions
Two different orientations of particles were considered in this
work. After identifying three carbons in the cavity of the
nanoparticle and connecting them to deﬁne a plane, we
characterized the orientation angle as the angle between the
outward vector normal to the plane and the monolayer normal
(the z direction) (see Fig. 4). Fig. 5 shows the change of the
orientation angle as a function of simulation time. The initial
FIGURE 3 Evolution of the surface area (A˚2/lipid) over time for System I,
without the particle (dashed line), and System II, with the nanoparticle (solid
line).
FIGURE 4 Deﬁnition of the orientation angle for the nanoparticle. After
identifying three carbons in the cavity of the nanoparticle and connecting them
to deﬁne a plane, the orientation angle is deﬁned as the angle between the out-
ward vector normal to the plane and the monolayer normal (the z direction).
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orientations of the particles were the same in the two leaﬂets,
but their ﬁnal values changed after the minimization, heating,
and equilibration steps. In System II, the nanoparticle with an
initial angle of ;55 (Fig. 5, upper leaﬂet) oscillates around
this value, whereas the particle with an initial angle of 35
(Fig. 5, lower leaﬂet) reaches a value of 10 after only 2.5 ns.
The radial-distribution functions (RDFs), denoted as g(r),
give information on the probability of ﬁnding two molecules
at a mutual distance, r, once geometric and density factors
have been scaled out. Fig. 6 (upper), shows the RDFs be-
tween the tails of the lipids (the last CH3 in the chain) and the
center of mass of the nanoparticle in the upper and lower
leaﬂets. Since the two curves look very similar, the particle
orientation does not inﬂuence the interactions between the
lipids and the particle itself. The ﬁrst two peaks for r , 5 A˚
are due to the presence of the lipid tails inside the cavity of the
nanoparticles. No coating or wrapping of the lipids around
the nanoparticles has been detected, since the RDFs show a
third peak at a distance of r  11 A˚, much greater than the
radius of the particle.
Fig. 6 (lower), reports the RDFs between the phosphorus
(P) in the headgroup of lipids and the center of mass of the
nanoparticle for the upper and lower leaﬂets in System II. The
orientation in this case has an inﬂuence on the RDFs.
To determine whether this is due to the position of the
nanoparticle or to its orientation, we analyzed the change of
position of the center ofmass of the particle over time (see Fig.
7). The two curves appear to be very similar, and hence the
position of the nanoparticle does not explain the difference in
RDFs. The different orientations of the nanoparticle can in-
stead justify the difference reported in Fig. 6 (lower). The
presence of the nanoparticle perturbs the local lipid density by
pushing the neighboring lipid molecules away from the
nanoparticle, which was also shown by Chang and Violi (52).
This behavior is clearly observed in the additional simulations
described in Supplementary Material (Data S1), in which the
nanoparticle is located initially above the lipid molecules and
then reaches the lipids during the equilibration stage.
Mean-square displacement and diffusion
Fig. 8 shows the mean-square displacement (MSD) of the
center of mass of a single DPPC lipid and the nanoparticle
in the directions parallel ðÆDR2x1DR2yæ=4[ ÆDR2lateralæ=4Þ and
normal ðÆDR2zæ=2[ ÆDR2normalæ=2Þ to the monolayer. The MSD
results were averaged over the two leaﬂets. We show only 2 ns
MSD from System II.
Initially, lateral diffusion of the single lipid is similar to
that of the nanoparticle, but as the simulation proceeds, the
nanoparticle reaches lower values compared to the lipid. We
infer that this might be due to the presence of lipids inside the
nanoparticle that hinder the motion of the particle. The same
effect is obtained for normal diffusion of the nanoparticle
FIGURE 5 Change of the nanoparticle orientation angle as a function of sim-
ulation time. The nanoparticle with an initial angle of;55 (System II, upper
leaﬂet) oscillates around this value, whereas the particle with an initial angle of
35 (System II, lower leaﬂet) reaches a value of 10 after only 2.5 ns.
FIGURE 6 Two-dimensional radial distribution functions, g2D, of the
lipid tails (upper) and the headgroup (P) (lower) around the nanoparticle.
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when compared with that of the single lipid. It is interesting to
note that normal diffusion of the nanoparticle is signiﬁcantly
smaller than that of single lipids, whereas lateral diffusion is
similar. A similar behavior was already reported by Chang
and Violi (52), who found that the slowdown of the round
nanoparticle in the normal direction results from its heavy
mass. The normal diffusion clearly shows that a lipid mole-
cule and a nanoparticle are conﬁned to local ranges of z after
1.7 or 1.8 ns. Conﬁnement of the nanoparticle in the normal
direction can be seen in Fig. 7.
Schram and Hall reported that at all temperatures, diffu-
sion in surfactant lipids becomes slower with surfactant
proteins SP-B and SP-C, and the diffusion coefﬁcient of the
single lipid is ;1.5 3 103 A˚2/ps (56). The diffusion coef-
ﬁcient can be obtained from the slope of the corresponding
MSD curve. In our simulations, however, it is clear that the
Brownian regime has not been reached, because the MSDs
versus time are not linear. It is therefore not possible to use
the Einstein relation to extract diffusion constants. Long-time
diffusion of single lipids is usually slower than short-time
diffusion. Compared to the experimental value (56) obtained
from the long-time scale diffusion, the magnitude of lateral
diffusion from our short-time scale simulations seems to
conﬁrm this. It is known that there are two regimes for lateral
diffusion, i.e., short-time free volume displacements and
long-time lipid motion (57–60). InWohlert and Edholm (60),
it was shown that in a ﬁrst stage occurring at short times, t, 5
ns, the center of the lipid moves due to conformational
changes of the chains, whereas the headgroup position re-
mains relatively ﬁxed.
Order parameters SCH and SCC
Another interesting property for the systems analyzed in this
work is the C-H bond order parameter, SCH, which can be
compared to the carbon-deuterium order parameter, SCD,
from NMR measurements, and which is a measure of the
chain behavior. In MD simulations, the order parameter SCH
can be obtained for the nth carbon in the chain using the
expression (61)
S
n
CH ¼
2
3
S
n
xx1
1
3
S
n
yy; (2)
where Sij ¼ Æ3cosuicosuj – dijæ/2 (ui is the angle between the
ith molecular axis and the monolayer normal (z axis). Fig. 9
(upper) shows the values of SCH averaged over the different
chains in the monolayer and over the two leaﬂets. System I is
more condensed than System II, and thus the chain results are
more ordered. The computed results for System I agree well
with previously published experiments (62), as well as com-
puter simulations (63), where the values obtained for SCH
were 55 A˚2/lipid and 60 A˚2/lipid for DPPC and dipalmitoyl-
phosphatidylglycerol monolayers, respectively. It is experi-
mentally challenging to quantify the conformational order in
monolayers because NMR and infrared spectroscopy may not
be sufﬁciently sensitive. Using infrared reﬂection-absorption
spectroscopy, Gericke et al. (62) reported that for DPPC
monolayers, the region near the headgroup is more ordered
than the region at the tail end, and that compression results in
increased ordering. Our simulation results are in agreement
with the experimental observations, and others have already
conﬁrmed this in previous MD simulations (63).
Morrow et al. (64) and Dico et al. (65) reported that for
protein concentrations up to 11% (w/w), SP-B perturbs
DPPC chain order only slightly in the liquid-crystalline
phase. It has also been found that SP-B/C (a mixture of the
two hydrophobic surfactant proteins) appears to have little or
only a slight ordering effect on the PC component (66). Thus,
we compared the computed chain order with data from the
neat monolayer (62). Note that the protein concentration in
FIGURE 7 Evolution of the position of the center of mass of the nano-
particle over time, showing the z component only.
FIGURE 8 MSDs of a single DPPC lipid (thick solid line, ÆDR2lateralæ=4;
thick dashed line, ÆDR2normalæ=2), and the round nanoparticle (thin solid line,
ÆDR2lateralæ=4; thin dashed line, ÆDR2normalæ=2Þ from System II.
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our system is ,11% (w/w) (,9% (w/w)). In fact, the vari-
ation of the chain order depends on the concentration of SP-B.
Using 2H NMR spectra, Morrow et al. reported that the chain
order was changed signiﬁcantly in the presence of 15% SP-B
(67). In our simulations, the total average values for SCH along
the chain are 0.30 and 0.28 for Systems I and II, respectively.
The value of 0.30 for System I is slightly larger than values
found in previousMD simulations for pure DPPCmonolayers
(63,68). Note that the order parameters also depend on tem-
perature, surface area/lipid, and hydration level, and these
factors could justify the discrepancy.
Recently, it has been shown that additional information
about the chain conformation can be obtained by computing
the carbon-carbon order parameter, SCC, (69,70) as follows:
SCC ¼ 1
2
Æ3cos2ðfnÞ  1æ; (3)
where fn is the angle between the normal of the monolayer
and the bond connecting carbon atoms Cn1 and Cn. The SCC
order parameter formalism is of great interest for understand-
ing the conformational properties of acyl chains. It makes
possible the calculation of conformer probabilities and acyl
chain length, and in combination with neutron scattering
experiments, it provides information about protrusion of
lipids in the membrane (70). Fig. 9 (lower) shows the SCC
averaged over the two chains of the lipid and over the two
leaﬂets of the monolayer. In System I, we can clearly see the
difference between the odd and even order parameters, the
so-called odd-even effect (71). In System II, the odd-even
effect becomes smaller, and the even order parameter is larger
than the odd one. The total averages along the chain are 0.27
and 0.25 for Systems I and II, respectively.
Moreover, the SCC order proﬁle may reveal an odd-even
effect that cannot be observed for SCH measured from deu-
terated chains. The SCC order parameter proﬁles exhibit an
odd-even effect especially for positions near the polar head.
This effect might be a consequence of the average bent
conformation of the beginning of the chain. In our calcula-
tions, this effect occurs at the beginning of the chain and is
less evident after position 13. This could mean that the av-
erage orientation of the chain is tilted with respect to the
z direction.
Toward the end of the chain, the SCC and SCH proﬁles are
similar, accounting for the increase in conformational free-
dom. This odd-even effect has already been observed on sn-2
DLPC, DMPC, and DPPC (69) palmitic acid and on sn-1
DMPC chains (70).
Fig. S1 in the Supplementary Material (Data S1) shows
SCH and SCC for each leaﬂet in System I. The lipids in the
upper leaﬂet are slightly more ordered than those in the lower
leaﬂet. This suggests that the orientation of the nanoparticle
could change the order parameters, but the amount is very
small in our simulations.
Chain tilt angle
The chain tilt angle is deﬁned as the angle between the
monolayer normal and the tilt vector, which is drawn from
the center of the ﬁrst and second carbons to the center of the
13th and 14th carbons in the chain of DPPC lipid molecules.
The most probable tilt angle is ;20 for both systems, as
reported in Fig. 10 (upper). The average values of the angle
are 24.6 6 8.8 and 24.6 6 7.5 for Systems I and II, re-
spectively. The results do not show an inﬂuence of the
nanoparticle on the chain tilt angle.
Bringezu et al. reported the chain tilt angle as a function of
the surface pressure, and at a pressure of 40 mN/m, the chain
tilt angles were 106 1 (M2) and 156 1 (M3), respectively
(34). Here, M2 is a mixture of DPPC/POPG/PA1 SP-B1–78,
and M3 is a mixture of DPPC/POPG/PA 1 dSP-B1–25. Ac-
cording to Table 1 of Bringezu et al. (34), SP-B1–78 has only a
slight effect on the chain tilt angle for the DPPC/POPG/PA
mixture over the whole surface pressure range. It is inter-
esting to note that the tilt angle computed from our simula-
tions is in good agreement with the values reported from
FIGURE 9 Order parameter jSCHj (upper) and SCC (lower) averaged over
the different chains in the monolayer and over the two leaﬂets. System I (w/o
particle) is more condensed than System II (with particle) and thus the chain
results are more ordered.
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experiments (72–74), as well as with those obtained from
computer simulations (68) on pure DPPC lipids.
On the other hand, Gericke et al. reported that the acyl
chain tilt angle of DPPC decreased from ;26 in pure lipid
monolayers to ;10 in the mixed monolayer ﬁlms (DPPC/
SP-C) using the external infrared reﬂection-absorption spec-
troscopy (75).
Choline headgroup dipole (P-N) orientation
For the DPPC monolayer, using surface potential measure-
ments, it has been suggested that the headgroup orientation is
parallel to the air-water interface (76), and in a previous
simulation, the average angle between the water surface and
the P-N dipole was determined to be 5 (68).
The P-N tilt angle is deﬁned in this article as the angle
between the P-N vector and the monolayer normal. The in-
teraction between the P-N dipole and the external perturbing
surface charges causes the headgroup to tilt toward or away
from the monolayer, depending on the sign of the net surface
charge. The headgroup tilts toward the water phase (toward
the monolayer normal) in the presence of a positive surface
charge. In the presence of a negative surface charge, the
headgroup tilts toward the monolayer interior (away from
monolayer normal). Since SP-B1–25 has a positive net charge,
the P-N tilt angle should be ,90–95, which was the value
range obtained for pure DPPC lipids.
Our simulations show an angle of ;70 for the two sys-
tems (Fig. 10 (lower)). The average angle is 71.46 17.3 for
System I and 70.16 18.3 for System II. This result suggests
that the presence of the nanoparticle does not change the P-N
tilt angle, as is expected, since the nanoparticle is neutral and
has no dipole moment.
Helix tilt angle
The preferred conformation of the SP-B1–25 peptide in vari-
ous lipid environments is still the subject of many studies.
Several experimental measurements (77,78) and computer
simulations (35,36,79,80) have been reported in the litera-
ture. To our knowledge, Frietes et al. (35) performed the only
simulation that attempted a direct comparison with experi-
mental data (x-ray scattering).
In our system, the nanoparticle interacts with the lipid
molecules as well as with SP-B1–25. It is therefore interesting
to get insights into the interactions between the nanoparticle
and the SP-B1–25 by computing the helix tilt angle. To deﬁne
the helix tilt angle, we use the same coordinate system pro-
posed by Choe and Sun (81). First, we deﬁne a center of mass
using three Cas, e.g., using Cas in residues 10–12, 14–16,
and 18–20. We named them c1, c2, and c3, respectively. Next,
t1 and t2 are deﬁned by connecting each center of mass: t1 ¼
c1c2
! and t2 ¼ c1c3!. Two different schemes are used in this
article. In Scheme I, the helix tilt angle is deﬁned as the angle
between t2 and the monolayer normal, and in Scheme II, the
helix tilt angle is the angle between the average of two vectors
(t11 t2)/2 and the monolayer normal. Note that we averaged
the tilt angles over two SP-B1–25 peptides. In System I, the
average helix tilt angles are 52.16 9.1 and 50.26 8.9 from
Schemes I and II, respectively. These values are similar to
FIGURE 10 Angular distribution of the chain tilt angle (upper) and the
P-N tilt angle (lower).
FIGURE 11 Probability distribution of the headgroup (P) around the
center of mass of the N-terminal tail (residues 1–9).
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those reported in the literature. The peptide is initially tilted
by ;45 with respect to the normal. In the presence of the
nanoparticle (System II), the average helix tilt angle becomes
smaller, 31.06 5.4 and 30.86 6.2 from Schemes I and II,
respectively. The nanoparticle pushes the peptide away from
the interface by almost 20 (System I and System II). This
might suggest that the two hydrophobic molecules (the
nanoparticle and the SP-B1–25) repel each other.
Thehelix tilt angle couldalso beaffectedby theorientationof
the nanoparticle. Although the average helix tilt angle over the
two leaﬂets is;30, the tilt angle of the two SP-B1–25 peptides
in each leaﬂet is different. The tilt angles are 21.2 6 9.1 and
40.56 8.2 for the upper and lower leaﬂets, respectively.
The different angles are a consequence of the different
interactions of the nanoparticle with the headgroup shown in
Fig. 6 (lower), in the two leaﬂets. In Fig. 6 (lower), the
nanoparticle in the upper leaﬂet shows more repulsive in-
teraction with the lipid headgroups. This can cause some
different interactions of the headgroups with SP-B1–25, and
thus the helix tilt angle could be also affected and possibly
affect the proper functioning of the SP-B1–25.
The N-terminal tail (residues 1–9) of SP-B is particularly
critical for the surface-tension-reducing property of the pro-
tein (82). Thus, the position and depth of those residues are
important for SP-B (and SP-B1–25) to function. Fig. 11 re-
ports the probability distribution function of the headgroup
(P) around the center of mass of those nine residues. The ﬁrst
peak is shifted (;5 A˚) in the presence of the nanoparticle, and
this can be further evidence that the nanoparticle can affect
the interaction between the headgroup and SP-B1–25. The
position of the ﬁrst peak in the radial distribution is also
slightly dependent on the orientation of the nanoparticle (not
shown), but the amount of the shift is very small, ;1 A˚.
Potential of mean force for
nanoparticle translocation
Fig. 12 shows the PMF for nanoparticle translocation across
the monolayer. In Fig. 12 a, the PMF from the combination of
upper and lower monolayers (j1 and j2, respectively) is
shown together with individual results. In Fig. 12 b, the
PMFs of three 0.25-ns long subblocks (Samples 1–3) are
displayed after subtracting the PMF of the entire 0.75-ns
sample. The two individual PMF curves in Fig. 12 a agree
with the combined PMF labeled ‘‘All’’ within ;1.5 kcal/
mol. The nanoparticle penetration into the monolayer
is represented by a monotonic decrease in the PMF between
j ¼ 26 A˚ and j ¼ 8 A˚. In particular, the nanoparticle
makes contact with the monolayer from the vacuum phase at
j 21 A˚, but it is not noticeable from the PMF. However, we
note a small change in the slope of PMF at j ¼ 24 A˚, which
might be indicative of the adsorption of nanoparticle on the
lipids. The nanoparticle is most stable inside the monolayer at
j ¼ 8 A˚, where maximum interaction between the nano-
particle and the lipid acyl chains is possible.
As the nanoparticle moves further toward the lipid head-
group region, the PMF begins to rise, and this trend continues
until the nanoparticle is partially exposed to the water phase
at j  9 A˚. Because of the limited range of the reaction
coordinate, the PMF does not exhibit a plateau at either large
or small j. Thus, it is difﬁcult to determine the relative sta-
bility of the nanoparticle in the vacuum and water phases.
However, as reported in Fig. 12 b, the PMF tends to change
systematically with longer sampling. For example, the PMF
from Sample 3 in Fig. 12 b (0.75–1 ns) is larger than that of
the shorter samples (Fig. 12 b, Samples 1 and 2: 0.25–0.5 and
0.5–0.75 ns, respectively) in the vacuum region (j . 21 A˚).
On the other hand, the PMF tends to decrease at j, 0 A˚ with
longer sampling. Thus, with longer sampling, the nano-
particle is expected to be more stable in the water than in the
vacuum phase. From Fig. 12 b, we estimate the uncertainty in
the PMF of Fig. 12 a as 15 kcal/mol in the vacuum and
–2 kcal/mol in the water side.
The umbrella sampling was performed without any re-
straint on the nanoparticle orientation. Since the sample was
initially prepared with the nanoparticle in the vacuum region,
FIGURE 12 Potential of mean force (PMF) for nanoparticle translocation
across the monolayer. (a) The PMF obtained from the upper (j1) and lower
(j2) monolayer-nanoparticle pair and from the combined samples (‘‘All’’)
are displayed. A large value of j corresponds to a nanoparticle in the vacuum
phase and a small j to a nanoparticle in the water phase. The PMF cal-
culation was performed using the last 0.75-ns portion of the 1-ns long
sample. (b) PMF from three 0.25-ns long samples (Sample 1, 0.25–0.5 ns;
Sample 2, 0.5–0.75 ns; Sample 3, 0.75–1.0 ns) are shown after subtracting
the PMF from the combined sample (All).
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the nanoparticle was allowed to freely rotate. Inspection
of the sampled conﬁguration reveals that the nanoparticle
faces the monolayer with its convex side in the region near
the monolayer (data not shown). This is understandable,
because this conﬁguration is expected to maximize the at-
tractive Lennard-Jones interaction between the nanoparticle
and the lipid acyl chains. It was also found that this nano-
particle orientation is maintained during the entire translo-
cation process. This will minimize possible entanglement of
lipid acyl chains in the cavity of the nanoparticle and facili-
tate the movement of the nanoparticle. If the translocation
had been initiated in the water phase, the nanoparticle would
have assumed the reverse orientation. The sampling de-
scribed here is too short to allow for nanoparticle reor-
ientation inside the monolayer, but the above considerations
indicate that this may not be a severe limitation.
A very interesting ﬁnding is the wrapping (or coating)
during the umbrella sampling. The cavity of the nanoparticle
begins to be ﬁlled with lipid chains at a late stage of pene-
tration. Fig. 13 depicts the wrapping during the umbrella
sampling. Only the lipid chains enter the cavity. For NP1 (the
nanoparticle in the upper leaﬂet), which has u  180, a
single lipid begins to occupy the cavity at j ¼ 1.75 A˚ by
wrapping its tail around the edge of the NP. For NP2 (the
nanoparticle in the lower leaﬂet), which is oriented more
sideways, this took place earlier, at j¼ 0.25 A˚. In the end, the
cavity is ﬁlled with two lipids. Similar behavior was reported
for a C60 molecule adsorbed deeply in the bilayer (83).
CONCLUSIONS
We performed MD simulations to study the effects of the
presence of a carbonaceous nanoparticle in a lung surfactant
composed of DPPC and SP-B1–25 peptides. Two systems
were considered: System I, composed of DPPC, SP-B1–25,
and water; and System II, obtained by adding a nanoparticle
to System I. The NLzgT ensemble was used for the simula-
tions with a surface tension of g ¼ 20.0 dyn/cm. We com-
puted various properties of the systems, including the radial
distribution functions, the mean-square displacements, the
FIGURE 13 Lipid wraps its tail around the nanoparticle
during the umbrella sampling. The top view on each leaﬂet
is shown at j ¼ 0.25, –1.75, and 9.25 A˚, respectively.
The lipid molecules are represented by vdW radii and the
nanoparticle is colored orange (left, NP1; right, NP2). (a) j
¼ 0.25 A˚. The NP2 cavity is ﬁlled with two acyl chains
from two different lipids. This is the earliest point at which
lipids enter the cavity. (b) j ¼ 1.75 A˚. The NP1 cavity is
ﬁlled with one acyl chain. This is where the NP1 cavity is
ﬁlled with a lipid chain for the ﬁrst time. (c) j ¼ 9.25 A˚.
This is close to the end of the PMF. This shows that the NP1
and NP2 cavities are ﬁlled with two acyl chains. Note that
one of them has two chains from a single lipid, whereas the
other has one chain from two different lipids.
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order parameters (SCH and SCC), the chain tilt angle, the P-N
orientation, the helix tilt angle, and the PMF of the permea-
tion. It is noted that during the simulations a lipid wraps its
tail around the nanoparticle, and that by the end of the sim-
ulations the cavity is ﬁlled with one or two lipids. In addition,
the orientation of the nanoparticle has an inﬂuence on the
lipid chain order. The nanoparticle investigated in this article
is not symmetric, and the interactions with other molecules
(lipids, SP-B1–25) are also inﬂuenced by the particle orien-
tation. The major effect of the nanoparticle on lung surfactant
is the interaction between the nanoparticle and SP-B1–25. Our
simulations show that they repel each other. The PMF cal-
culation clearly shows that carbon nanoparticles strongly
adsorb in the tail region of the lung surfactant monolayer
once they are inhaled. On the other hand, it is unlikely for the
adsorbed nanoparticles to easily translocate into the water
phase, because the free energy barrier for the nanoparticle
translocation is too high to be overcome simply by thermal
ﬂuctuation, which is ;0.6 kcal/mol at ambient temperature.
A similar behavior was also found in the previous bilayer
simulations (52). It would be interesting in the future to study
the PMF between SP-B1–25 and the nanoparticle with an
additional umbrella sampling.
The variation of results in the experimentally determined
position and orientation of SP-B and DPPC layers suggests
that there is no speciﬁcity in the interactions between SP-B
and DPPC lipids. It also has been proposed that the topograph-
ical and structural organization of SP-B may depend on exper-
imental conditions (84–87). A recent simulation showed that
in DPPC monolayers, SP-B1–25 mainly interacts with the zwit-
terionic lipid through hydrophobic interactions (36). Frietes
et al. also suggested that both hydrophobic interactions and salt
bridges are important (35). It is worth mentioning that, to date,
the study described by Frietes et al. (35) is the simulation on
the SP-B peptide in a lipid monolayer that has been most ex-
tensively validated experimentally. It has also been shown that
the polar and cationic amino acids of the peptide form hy-
drogen bond interactions with headgroups of lipids, and it
was suggested that these hydrogen bonds help determine the
position and orientation of the peptide on the interface (79).
Although the correct position and the helix tilt angle of
SP-B1–25 have not yet been established, the nanoparticle can
affect the interaction between the lipids and the peptide, and it
can hinder the function of lung surfactant. More quantitative
analyses will be necessary to conﬁrm these theories.
In this work, we didn’t consider any radical formation or
oxidation. The effect of chemically modiﬁed carbon nano-
particles on lung surfactant can be interesting. In addition, the
effect of particle morphology on the surfactant is another
research subject of interest.
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